Report Detail
Global Next-Generation Tumor Genetic Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM4579309 |
- 29 March, 2024 |
- Global |
- 104 Pages |
- GIR (Global Info Research) |
- Service & Software
According to our (Global Info Research) latest study, the global Next-Generation Tumor Genetic Testing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Next-Generation Tumor Genetic Testing industry chain, the market status of Hospitals (Fluorescence In Situ Hybridization, Polymerase Chain Reaction), Speciality Clinics (Fluorescence In Situ Hybridization, Polymerase Chain Reaction), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Next-Generation Tumor Genetic Testing.
Regionally, the report analyzes the Next-Generation Tumor Genetic Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Next-Generation Tumor Genetic Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Next-Generation Tumor Genetic Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Next-Generation Tumor Genetic Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Fluorescence In Situ Hybridization, Polymerase Chain Reaction).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Next-Generation Tumor Genetic Testing market.
Regional Analysis: The report involves examining the Next-Generation Tumor Genetic Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Next-Generation Tumor Genetic Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Next-Generation Tumor Genetic Testing:
Company Analysis: Report covers individual Next-Generation Tumor Genetic Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Next-Generation Tumor Genetic Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Speciality Clinics).
Technology Analysis: Report covers specific technologies relevant to Next-Generation Tumor Genetic Testing. It assesses the current state, advancements, and potential future developments in Next-Generation Tumor Genetic Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Next-Generation Tumor Genetic Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Next-Generation Tumor Genetic Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Market segment by Application
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Market segment by players, this report covers
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Next-Generation Tumor Genetic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Next-Generation Tumor Genetic Testing, with revenue, gross margin and global market share of Next-Generation Tumor Genetic Testing from 2019 to 2024.
Chapter 3, the Next-Generation Tumor Genetic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Next-Generation Tumor Genetic Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Next-Generation Tumor Genetic Testing.
Chapter 13, to describe Next-Generation Tumor Genetic Testing research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Next-Generation Tumor Genetic Testing
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Next-Generation Tumor Genetic Testing by Type
- 1.3.1 Overview: Global Next-Generation Tumor Genetic Testing Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Type in 2023
- 1.3.3 Fluorescence In Situ Hybridization
- 1.3.4 Polymerase Chain Reaction
- 1.3.5 Microarray Technology
- 1.3.6 Serum Proteomics
- 1.3.7 Nucleic Acid Sequencing
- 1.4 Global Next-Generation Tumor Genetic Testing Market by Application
- 1.4.1 Overview: Global Next-Generation Tumor Genetic Testing Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospitals
- 1.4.3 Speciality Clinics
- 1.4.4 Research Institutes
- 1.4.5 Diagnostics Laboratories
- 1.4.6 Biopharmaceutical Companies
- 1.5 Global Next-Generation Tumor Genetic Testing Market Size & Forecast
- 1.6 Global Next-Generation Tumor Genetic Testing Market Size and Forecast by Region
- 1.6.1 Global Next-Generation Tumor Genetic Testing Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Next-Generation Tumor Genetic Testing Market Size by Region, (2019-2030)
- 1.6.3 North America Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
- 1.6.4 Europe Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
- 1.6.6 South America Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Next-Generation Tumor Genetic Testing Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Devyser
- 2.1.1 Devyser Details
- 2.1.2 Devyser Major Business
- 2.1.3 Devyser Next-Generation Tumor Genetic Testing Product and Solutions
- 2.1.4 Devyser Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Devyser Recent Developments and Future Plans
- 2.2 Agendia
- 2.2.1 Agendia Details
- 2.2.2 Agendia Major Business
- 2.2.3 Agendia Next-Generation Tumor Genetic Testing Product and Solutions
- 2.2.4 Agendia Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Agendia Recent Developments and Future Plans
- 2.3 Illumina
- 2.3.1 Illumina Details
- 2.3.2 Illumina Major Business
- 2.3.3 Illumina Next-Generation Tumor Genetic Testing Product and Solutions
- 2.3.4 Illumina Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Illumina Recent Developments and Future Plans
- 2.4 Personal Genome Diagnostics
- 2.4.1 Personal Genome Diagnostics Details
- 2.4.2 Personal Genome Diagnostics Major Business
- 2.4.3 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Product and Solutions
- 2.4.4 Personal Genome Diagnostics Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Personal Genome Diagnostics Recent Developments and Future Plans
- 2.5 Veracyte
- 2.5.1 Veracyte Details
- 2.5.2 Veracyte Major Business
- 2.5.3 Veracyte Next-Generation Tumor Genetic Testing Product and Solutions
- 2.5.4 Veracyte Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Veracyte Recent Developments and Future Plans
- 2.6 Pacific Biosciences of California
- 2.6.1 Pacific Biosciences of California Details
- 2.6.2 Pacific Biosciences of California Major Business
- 2.6.3 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Product and Solutions
- 2.6.4 Pacific Biosciences of California Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Pacific Biosciences of California Recent Developments and Future Plans
- 2.7 Qiagen
- 2.7.1 Qiagen Details
- 2.7.2 Qiagen Major Business
- 2.7.3 Qiagen Next-Generation Tumor Genetic Testing Product and Solutions
- 2.7.4 Qiagen Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Qiagen Recent Developments and Future Plans
- 2.8 Agilent Technologies
- 2.8.1 Agilent Technologies Details
- 2.8.2 Agilent Technologies Major Business
- 2.8.3 Agilent Technologies Next-Generation Tumor Genetic Testing Product and Solutions
- 2.8.4 Agilent Technologies Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Agilent Technologies Recent Developments and Future Plans
- 2.9 Natera
- 2.9.1 Natera Details
- 2.9.2 Natera Major Business
- 2.9.3 Natera Next-Generation Tumor Genetic Testing Product and Solutions
- 2.9.4 Natera Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Natera Recent Developments and Future Plans
- 2.10 Bio Rad Laboratories
- 2.10.1 Bio Rad Laboratories Details
- 2.10.2 Bio Rad Laboratories Major Business
- 2.10.3 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Product and Solutions
- 2.10.4 Bio Rad Laboratories Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 Bio Rad Laboratories Recent Developments and Future Plans
- 2.11 Myriad Genetics
- 2.11.1 Myriad Genetics Details
- 2.11.2 Myriad Genetics Major Business
- 2.11.3 Myriad Genetics Next-Generation Tumor Genetic Testing Product and Solutions
- 2.11.4 Myriad Genetics Next-Generation Tumor Genetic Testing Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 Myriad Genetics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Next-Generation Tumor Genetic Testing Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Next-Generation Tumor Genetic Testing by Company Revenue
- 3.2.2 Top 3 Next-Generation Tumor Genetic Testing Players Market Share in 2023
- 3.2.3 Top 6 Next-Generation Tumor Genetic Testing Players Market Share in 2023
- 3.3 Next-Generation Tumor Genetic Testing Market: Overall Company Footprint Analysis
- 3.3.1 Next-Generation Tumor Genetic Testing Market: Region Footprint
- 3.3.2 Next-Generation Tumor Genetic Testing Market: Company Product Type Footprint
- 3.3.3 Next-Generation Tumor Genetic Testing Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Next-Generation Tumor Genetic Testing Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Next-Generation Tumor Genetic Testing Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Next-Generation Tumor Genetic Testing Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Next-Generation Tumor Genetic Testing Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
- 6.2 North America Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
- 6.3 North America Next-Generation Tumor Genetic Testing Market Size by Country
- 6.3.1 North America Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2030)
- 6.3.2 United States Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 6.3.3 Canada Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
- 7.2 Europe Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
- 7.3 Europe Next-Generation Tumor Genetic Testing Market Size by Country
- 7.3.1 Europe Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2030)
- 7.3.2 Germany Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 7.3.3 France Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 7.3.5 Russia Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 7.3.6 Italy Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Next-Generation Tumor Genetic Testing Market Size by Region
- 8.3.1 Asia-Pacific Next-Generation Tumor Genetic Testing Consumption Value by Region (2019-2030)
- 8.3.2 China Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 8.3.3 Japan Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 8.3.5 India Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 8.3.7 Australia Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
- 9.2 South America Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
- 9.3 South America Next-Generation Tumor Genetic Testing Market Size by Country
- 9.3.1 South America Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Next-Generation Tumor Genetic Testing Market Size by Country
- 10.3.1 Middle East & Africa Next-Generation Tumor Genetic Testing Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
- 10.3.4 UAE Next-Generation Tumor Genetic Testing Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Next-Generation Tumor Genetic Testing Market Drivers
- 11.2 Next-Generation Tumor Genetic Testing Market Restraints
- 11.3 Next-Generation Tumor Genetic Testing Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Next-Generation Tumor Genetic Testing Industry Chain
- 12.2 Next-Generation Tumor Genetic Testing Upstream Analysis
- 12.3 Next-Generation Tumor Genetic Testing Midstream Analysis
- 12.4 Next-Generation Tumor Genetic Testing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Next-Generation Tumor Genetic Testing. Industry analysis & Market Report on Next-Generation Tumor Genetic Testing is a syndicated market report, published as Global Next-Generation Tumor Genetic Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Next-Generation Tumor Genetic Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
